MILLER STRATEGIES, LLC

Lobbying for PFIZER INC. · pharmaceutical corporation

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $120,000.00 income · posted Jan 20, 2026

Lobbying activity 4

Medicare/Medicaid

Medicare and healthcare policy issues as they relate to drug pricing.

Health Issues

Oppose IRA, PREP Act and vaccine liability.

Taxation/Internal Revenue Code

General issues with tax reform and foreign tax issues.

Labor Issues/Antitrust/Workplace

Issues related to drug consolidation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.